Reovirus decreases azoxymethane-induced aberrant crypt foci and colon cancer in a rodent model.
- Published in:
- Cancer Gene Therapy, 2007, v. 14, n. 10, p. 867, doi. 10.1038/sj.cgt.7701068
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2007 AND VI 14 AND IP 10
Results: 7
1
2
IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer.
- Published in:
- Cancer Gene Therapy, 2007, v. 14, n. 10, p. 819, doi. 10.1038/sj.cgt.7701069
- By:
- Publication type:
- Article
3
Expression of the chemokine receptor CCR6 in the Lewis lung carcinoma (LLC) cell line reduces its metastatic potential in vivo.
- Published in:
- Cancer Gene Therapy, 2007, v. 14, n. 10, p. 847, doi. 10.1038/sj.cgt.7701074
- By:
- Publication type:
- Article
4
Cellular and molecular events associated with the antitumor response induced by the cytosine deaminase/5-fluorocytosine suicide gene therapy system in a rat liver metastasis model.
- Published in:
- Cancer Gene Therapy, 2007, v. 14, n. 10, p. 858, doi. 10.1038/sj.cgt.7701075
- By:
- Publication type:
- Article
5
Targeted-simultaneous expression of Gas1 and p53 using a bicistronic adenoviral vector in gliomas.
- Published in:
- Cancer Gene Therapy, 2007, v. 14, n. 10, p. 836, doi. 10.1038/sj.cgt.7701076
- By:
- Publication type:
- Article
6
Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors.
- Published in:
- Cancer Gene Therapy, 2007, v. 14, n. 10, p. 828, doi. 10.1038/sj.cgt.7701077
- By:
- Publication type:
- Article
7
IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer.
- Published in:
- 2007
- By:
- Publication type:
- Correction Notice